3650 results for «248»

Filter By

3650 results

Rapid-fire - Nightmares in the cathlab - Part 3

21 Nov 2023 – From PCR London Valves 2023

Consult this session to uncover challenging scenarios: navigate the complications of balloon-expanding TAVI embolization triggered by a Starr Edwards valve in the mitral position, delve into the nightmare of an embolic stroke post-TAVI in a patient with a porcelain aorta, explore the complexities of TAVR following two...

Rapid-fire - Nightmares in the cathlab - Part 3

Rapid-fire - Nightmares in the cathlab - Part 2

20 Nov 2023 – From PCR London Valves 2023

Challenges in TAVIs, are there guideline recommendations?

20 Nov 2023 – From PCR London Valves 2023

The EAPCI consensus session emphasized the critical role of evaluating and managing coronary artery disease in TAVI candidates, especially in younger and lower-risk patients. Transcatheter heart valve choice influences future coronary access, emphasizing the need for optimized implantation techniques. In cardiogenic shock due to valvular heart...

Challenges in TAVIs, are there guideline recommendations?

Rapid-fire - Challenging TAVI procedures - Part 4

20 Nov 2023 – From PCR London Valves 2023

Join this session for insights and innovative solutions to challenging TAVI procedures: explore the dynamics of peri-procedural ST-elevation myocardial infarction during TAVR, witness shifting left ventricular and hemodynamic physiology, unravel a curious case of valve-in-valve TAVR with a crossability challenge, confront the obstructive dilemma of high...

Rapid-fire - Challenging TAVI procedures - Part 4

Rapid-fire - TAVI complications - Part 2

20 Nov 2023 – From PCR London Valves 2023

Navigate through various TAVI complications with this selection of cases: learn more about a successful coronary complication handling, gain insights into a year-long follow-up on aortic dissection post-TAVR, witness unexpected twists like late balloon aortic valvuloplasty complications, and much more!

Rapid-fire - TAVI complications - Part 2

!!!NEWSFLASH!!! Long-term outcomes of the TAVI low risk trials - from headlines to clinical practice

20 Nov 2023 – From PCR London Valves 2023

Join this session to navigate through the long-term outcomes of TAVI low-risk trials (Partner 3, Evolut Low Risk...), to enhance your ability to synthesize and interpret clinical evidence and to learn how to seamlessly integrate these insights into your Heart Team's daily clinical practice.

!!!NEWSFLASH!!! Long-term outcomes of the TAVI low risk trials - from headlines to clinical practice

TAVI - Coronary access

21 Nov 2023 – From PCR London Valves 2023

Delve into the complexities of TAVI and coronary access with this session: explore the use of IVUS in assessing coronary arteries at high risk for obstruction following valve-in-valve TAVI, witness the application of patient-specific computer simulation to predict coronary re-access post-TAVI in bicuspid anatomy, navigate the...

TAVI - Coronary access

Transcatheter mitral valve replacement

20 Nov 2023 – From PCR London Valves 2023

Consult this session for key insights into diverse TMVR challenges: discover unique scenarios such as para-holes post-Tendyne implant, TMVR in a patient with severe mitral annular calcification, a complex case involving mitral para-ring leak and stenosis with a two-step treatment and an atypical LAMPOON indication, and more!

Transcatheter mitral valve replacement

RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure

01 Sep 2024

Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.

The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...

Nicola Ryan

Author

Nicola Ryan
RESHAPE-HF2

Insights from the Corevalve US Pivotal and SURTAVI trials

05 Apr 2022

Pierre Deharo and Giuseppe Di Gioia provide their take on this analysis of the 5 years incidence, outcomes and predictors of hemodynamic SVD in patients undergoing TAVI and surgery from the Corevalve US Pivotal and SURTAVI trials.

Pierre Deharo

Author

Pierre Deharo
Giuseppe Di Gioia

Author

Giuseppe Di Gioia
Insights From the Corevalve US Pivotal and SURTAVI Trials
Didn’t find what you were looking for?